Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood

Fruitura Bioscience

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Placebo

Dietary Supplement: RGC

Study type

Interventional

Funder types

Industry

Identifiers

NCT01832584

RGC-04

Details and patient eligibility

About

This is a 3-arm double blind placebo controlled study to investigate the effect of Red Grape Cell (RGC) powder containing all the matrix of polyphenols that can be found in red grapes. polyphenols have several beneficial effects on various body systems, are present in many edible foods, and are considered safe for human consumption by regulatory authorities. Animal and human studies suggest a potential for polyphenol-rich compounds in enhancing mitochondrial activity and exercise capacity. However, the effect of RGC on exercise performance in humans had not yet been tested. A special population where increasing performance is highly sought are competitive athletes. The aim of the current study is to investigate the effect of RGC on measures of aerobic fitness, body composition and mood in trained male cyclists

Enrollment

45 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age 18 - 65 years, men only
Active in cycling training group
Willingness to avoid regular use of NSAIDS (Advil, Nurofen, etc.) and aspirin for the entire study period
Without a history or evidence of significant cardiovascular, hepatic, renal, respiratory, hematopoietic, gastrointestinal disease, endocrine, metabolic, psychiatric or psychological disorders;
Willingness to avoid regular ingestion of any foods containing peanuts, bilberries, blueberries, cranberries, strawberries, raspberries, grapes, grape juice, cocoa powder, dark chocolate, red wine, over-the-counter medications, herbs, or supplements throughout the entire study, and to record and report any occasional consumption of such substances

Exclusion criteria

Any acute medical situation (e.g., acute infection, nausea and vomiting, diarrhea) 48 hours prior to initiation of the study, which is considered of significance by the principal investigator.
Any known chronic medical condition (will be determined by the principal investigator)
History or evidence of alcohol or drug abuse
Any gastrointestinal surgery other than appendectomy or herniotomy;
Current use of over the counter or prescription weight loss medication
Current use or within the last 30 days, any cholesterol lowering medications (statins, fibrates, red yeast rice, niacin).
Known allergy to casein and/or soy.
Subjects who had participated in a drug trial 3 months before initiation of the study;
Non-cooperative subjects or unwilling to sign an informed consent and participate in the study